Company profile: Prometheus Biosciences
1.1 - Company Overview
Company description
- Provider of novel pharmaceutical and diagnostic products to help physicians individualize patient care, developing and commercializing therapies including injections such as WINREVAIR (sotatercept-csrk) and KEYTRUDA (pembrolizumab), vaccines and biologic therapies; also conducts research, offers patient support programs, and markets Entocort EC, a glucocorticosteroid.
Products and services
- Research: Activities focused on the discovery and development of new pharmaceuticals to help physicians individualize patient care, discovery-and-development-focused
- Biologic Therapies: Treatments derived from biological sources that the company develops and commercializes to help physicians individualize patient care, biologically-derived
- WINREVAIR (sotatercept-csrk) for Injection: A pharmaceutical product designed for injection to help physicians individualize patient care, injectable
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prometheus Biosciences
C2 Therapeutics
HQ: United States
Website
- Description: Provider of ablation therapies to treat diseases of the gastrointestinal tract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full C2 Therapeutics company profile →
LAT Pharma
HQ: United States
Website
- Description: Provider of discovery, development, and commercialization of novel drug therapies for people with advanced liver cirrhosis and its life-threatening complications, initially targeting ascites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LAT Pharma company profile →
Lexington Medical
HQ: United States
Website
- Description: Provider of minimally invasive surgical stapling solutions, manufactured by a Boston-based medical device company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexington Medical company profile →
Envizion Medical
HQ: Israel
Website
- Description: Provider of electromagnetic feeding tube placement devices, including the ENvue System, which uses navigation, integrated sensors, and body mapping to ensure safe, rapid placement, and the ENvue Enteral Feeding Tube with built-in sensors that activate in electromagnetic fields for accurate placement and post-procedure position checks without re-insertion.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Envizion Medical company profile →
Given Imaging
HQ: United States
Website
- Description: Provider of GI medical devices, offering the broadest portfolio of capsule solutions to visualize the gastrointestinal tract and, through its Sierra Scientific subsidiary, specialty GI diagnostic solutions and high-resolution manometry; pioneered capsule endoscopy, now the gold standard.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Given Imaging company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prometheus Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prometheus Biosciences
2.2 - Growth funds investing in similar companies to Prometheus Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prometheus Biosciences
4.2 - Public trading comparable groups for Prometheus Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →